Advertisement
UK markets close in 1 hour 51 minutes
  • FTSE 100

    8,072.85
    +28.04 (+0.35%)
     
  • FTSE 250

    19,769.13
    -30.59 (-0.15%)
     
  • AIM

    755.25
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1639
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2450
    -0.0002 (-0.02%)
     
  • Bitcoin GBP

    53,092.66
    -120.51 (-0.23%)
     
  • CMC Crypto 200

    1,428.07
    +3.97 (+0.28%)
     
  • S&P 500

    5,085.76
    +15.21 (+0.30%)
     
  • DOW

    38,466.22
    -37.47 (-0.10%)
     
  • CRUDE OIL

    83.00
    -0.36 (-0.43%)
     
  • GOLD FUTURES

    2,333.30
    -8.80 (-0.38%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,139.70
    +2.05 (+0.01%)
     
  • CAC 40

    8,130.52
    +24.74 (+0.31%)
     

P&G raises full-year forecast on higher demand for beauty products

The logo for Procter & Gamble Co. is displayed on a screen on the floor of the NYSE in New York

(Reuters) - Procter & Gamble Co <PG.N> on Tuesday raised its full-year sales and profit forecasts after a better-than-expected first quarter, powered by demand for its premium beauty brands such as SK-II and China Olay.

The world's no.1 personal care products maker forecast full-year core earnings growth in the range of 5% to 10%, compared with its prior estimate of 4% to 9% growth.

P&G expects full-year sales to grow as much as 5%, compared to earlier expectation of 4%. The company retained the lower end of 3% growth.

Organic sales, which excludes acquisitions, divestitures and currency effects, rose 7% in the first quarter.

ADVERTISEMENT

The tide detergent maker saw solid growth in its beauty business and healthcare segment, with organic sales in its beauty business rising 10%.

Organic sales in the grooming unit, a sore point for the company, reported a 1% growth. It took an $8 billion writedown for its Gillette shaving business in the fourth quarter.

Overall, net sales climbed 6.6% to $17.80 billion, beating analysts' average estimate of $17.42 billion, according to IBES data from Refinitiv.

Net income attributable to the company rose to $3.59 billion, or $1.36 per share, in the three months ended Sept. 30, from $3.20 billion, or $1.22 per share, a year earlier.

Excluding items, it earned $1.37 per share, beating estimate of $1.24.

(Reporting by Soundarya J in Bengaluru; Editing by Bernard Orr)